Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Newspaper Publication

The Board of Directors of the Company in their meeting held on February 02, 2024 have approved the Unaudited standalone and consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2023, in this regard and pursuant to Reg 47 of LODR, we herewith enclose copy of Newspaper Advertisement dated February 3, 2024, published in Free Press Journal (English) and Navshakti (Marathi).
03-02-2024
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Investor Presentation

Revised Investor Presentation for the quarter ended December 31, 2023.
03-02-2024

Metropolis Healthcare Q3 results: Net Profit down 24% to Rs27 crore

The diagnostic services provider's operations predominantly relate to providing diagnostic services in pathology services.
02-02-2024
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Please find attached herewith, a copy of press release titled "Metropolis'' Core-Revenue Growth (Excl. Covid & Covid allied, PPP Contract) at Rs. 286 crs in Q3 FY24; up by 12% YoY%"
02-02-2024
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement under Regulation 30 (LODR)-Investor Presentation

Please find attached herewith, Investor Presentation for quarter ended December 31, 2023.
02-02-2024
Bigul

Metropolis Healthcare Ltd - 542650 - Announcement Under Regulation 30 Of SEBI (LODR), Reg, 2015, Regarding Change In Senior Management Personnel Of Company

Please find attached herewith, disclosure regarding change in Senior Management Personnel of the Company
02-02-2024
Bigul

Metropolis Healthcare Ltd - 542650 - Appointment of Company Secretary and Compliance Officer

Please find attached herewith, Disclosure of Appointment of Mr. Kamlesh Kulkarni, as Company Secretary and Compliance Officer of the Company, w.e.f February 03, 2024
02-02-2024
Bigul

Metropolis Healthcare Ltd - 542650 - Cessation Of Ms. Neha Shah, As Interim Company Secretary And Compliance Officer Of The Company W.E.F February 03, 2024

Please find attached herewith, disclosure for cessation of Ms. Neha Shah as Interim Company Secretary and Compliance Officer of the Company w.e.f February 03, 2024
02-02-2024
Bigul

Metropolis Healthcare Ltd - 542650 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E Friday, January 01, 2024

Please find attached herewith, Outcome of Board meeting held today i.e friday, January 01, 2024
02-02-2024
Bigul

Metropolis Healthcare Ltd - 542650 - Unaudited Financial Results (Standalone And Consolidated) For Quarter And Nine Months Ended December 31, 2023

Please find attached herewith, Unaudited Financial Results (Standalone & Consolidated) For quarter and nine months ended December 31, 2023.
02-02-2024
Next Page
Close

Let's Open Free Demat Account